Literature DB >> 33273211

Influences on Early Discontinuation and Persistence of Daily Oral PrEP Use Among Kenyan Adolescent Girls and Young Women: A Qualitative Evaluation From a PrEP Implementation Program.

Jillian Pintye1, Gabrielle O'Malley2, John Kinuthia2,3, Felix Abuna3, Jaclyn N Escudero2, Melissa Mugambi2, Mercy Awuor4, Annabell Dollah4, Julia C Dettinger2, Pamela Kohler2,5, Grace John-Stewart2,6,7, Kristin Beima-Sofie2.   

Abstract

BACKGROUND: Discontinuation of daily oral pre-exposure prophylaxis (PrEP) is frequent among adolescent girls and young women (AGYW) in African settings. We explored factors influencing early PrEP discontinuation and persistence among Kenyan AGYW who accepted PrEP within a programmatic setting.
METHODS: We conducted in-depth interviews with AGYW (aged 15-24 years) who accepted PrEP from 4 maternal child health (MCH) and family planning (FP) clinics. AGYW were identified by nurses at routine clinic visits and purposively sampled based on 4 categories: (1) accepted PrEP pills, but never initiated PrEP use (eg, never swallowed PrEP pills), (2) discontinued PrEP <1 month after initiation, (3) discontinued PrEP within 1-3 months, and (4) persisted with PrEP use >3 months. Informed by the Stages of Change Model, thematic analysis characterized key influences on PrEP discontinuation/persistence.
RESULTS: We conducted 93 in-depth interviews with AGYW who accepted pills. Median age was 22 years, 71% were married; 89% were from MCH, and 11% were from FP clinics. Early PrEP use was positively influenced by encouragement from close confidants and effective concealment of PrEP pill-taking when necessary to avoid stigma or negative reactions from partners. Pregnancy helped conceal PrEP use because pill-taking is normalized during pregnancy, but concealment became more difficult postpartum. AGYW found keeping up with daily PrEP pill-taking challenging, and many noted only episodic periods of the HIV risk. Frequently testing HIV-negative reassured AGYW that PrEP was working and motivated persistence. DISCUSSION: As PrEP programs scale-up in MCH/FP, it is increasingly important to enhance protection-effective PrEP use through approaches tailored to AGYW, with special considerations during pregnancy and postpartum.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33273211      PMCID: PMC8935942          DOI: 10.1097/QAI.0000000000002587

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  34 in total

1.  An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.

Authors:  Christina Psaros; Jessica E Haberer; Elly Katabira; Allan Ronald; Elioda Tumwesigye; James D Campbell; Jonathan Wangisi; Kenneth Mugwanya; Alex Kintu; Michael Enyakoit; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Norma Ware; Jared M Baeten; Connie Celum; David R Bangsberg; Steve A Safren
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

2.  Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.

Authors:  Timothy R Muwonge; Kenneth Ngure; Elly Katabira; Nelly Mugo; Grace Kimemia; Bridget Frances O'Rourke Burns; Nicholas Musinguzi; Felix Bambia; Jared M Baeten; Renee Heffron; Jessica E Haberer
Journal:  AIDS Behav       Date:  2019-05

Review 3.  Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline.

Authors:  Lara Esteves Coelho; Thiago Silva Torres; Valdiléa Gonçalves Veloso; Raphael J Landovitz; Beatriz Grinsztejn
Journal:  Lancet HIV       Date:  2019-09-23       Impact factor: 12.767

Review 4.  PrEP rollout in Africa: status and opportunity.

Authors:  Elizabeth M Irungu; Jared M Baeten
Journal:  Nat Med       Date:  2020-05-11       Impact factor: 53.440

5.  HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.

Authors:  Jillian Pintye; Kristin M Beima-Sofie; Pamela A Makabong'O; Anne Njoroge; Susan Brown Trinidad; Renee A Heffron; Jared M Baeten; Connie Celum; Daniel Matemo; John Kinuthia; Maureen C Kelley; Grace C John-Stewart
Journal:  AIDS Patient Care STDS       Date:  2018-07-23       Impact factor: 5.078

6.  Recent partner violence and sexual and drug-related STI/HIV risk among adolescent and young adult women attending family planning clinics.

Authors:  Michele R Decker; Elizabeth Miller; Heather L McCauley; Daniel J Tancredi; Heather Anderson; Rebecca R Levenson; Jay G Silverman
Journal:  Sex Transm Infect       Date:  2013-11-14       Impact factor: 3.519

7.  Brief Report: Integration of PrEP Services Into Routine Antenatal and Postnatal Care: Experiences From an Implementation Program in Western Kenya.

Authors:  Jillian Pintye; John Kinuthia; D Allen Roberts; Anjuli D Wagner; Kenneth Mugwanya; Felix Abuna; Harison Lagat; George Owiti; Carol E Levin; Ruanne V Barnabas; Jared M Baeten; Grace John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-15       Impact factor: 3.731

8.  Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.

Authors:  Jessica E Haberer; Jared M Baeten; James Campbell; Jonathan Wangisi; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Christina Psaros; Steven A Safren; Norma C Ware; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Connie Celum; David R Bangsberg
Journal:  PLoS Med       Date:  2013-09-10       Impact factor: 11.069

9.  To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.

Authors:  Kathrine Meyers; Yumeng Wu; Atrina Brill; Theodorus Sandfort; Sarit A Golub
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

Review 10.  Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.

Authors:  Megan S Dunbar; Katharine Kripke; Jessica Haberer; Delivette Castor; Shona Dalal; Wanjiru Mukoma; Saiqa Mullick; Pragna Patel; Jason Reed; Hasina Subedar; Daniel Were; Mitchell Warren; Kristine Torjesen
Journal:  Sex Health       Date:  2018-11       Impact factor: 2.706

View more
  11 in total

Review 1.  HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?

Authors:  Melissa Latigo Mugambi; Jillian Pintye; Renee Heffron; Ruanne Vanessa Barnabas; Grace John-Stewart
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-19       Impact factor: 5.495

2.  Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.

Authors:  Dvora Leah Joseph Davey; Kathryn Dovel; Susan Cleary; Nehaa Khadka; Nyiko Mashele; Miriam Silliman; Rufaro Mvududu; Dorothy C Nyemba; Thomas J Coates; Landon Myer
Journal:  BMC Public Health       Date:  2022-07-07       Impact factor: 4.135

Review 3.  Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.

Authors:  Dvora L Joseph Davey; Linda-Gail Bekker; Elizabeth A Bukusi; Benjamin H Chi; Sinead Delany-Moretlwe; Ameena Goga; Anne Drapkin Lyerly; Nyaradzo M Mgodi; Nelly Mugo; Landon Myer; Lisa M Noguchi; Lynda Stranix-Chibanda; Catherine Slack; Jillian Pintye
Journal:  Lancet HIV       Date:  2022-01-25       Impact factor: 16.070

4.  Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.

Authors:  Alexandra M Minnis; Juliane Etima; Petina Musara; Erica N Browne; Prisca Mutero; Doreen Kemigisha; Nyaradzo M Mgodi; Clemensia Nakabiito; Mary Kate Shapley-Quinn; Marie C D Stoner; Miriam Hartmann; Nicole Macagna; Jeanna Piper; Ariane van der Straten
Journal:  AIDS Behav       Date:  2022-06-08

5.  Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study.

Authors:  Elizabeth E Tolley; Andres Martinez; Seth Zissette; Thesla Palanee-Phillips; Florence Mathebula; Siyanda Tenza; Miriam Hartmann; Elizabeth T Montgomery
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

Review 6.  Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?

Authors:  Neeraja Bhavaraju; Kathleen Shears; Katie Schwartz; Saiqa Mullick; Patriciah Jeckonia; Joseph Murungu; Udita Persaud; Ashley Vij; Kristine Torjesen
Journal:  Curr HIV/AIDS Rep       Date:  2021-12-15       Impact factor: 5.071

7.  Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.

Authors:  Stephanie D Roche; Gena Barnabee; Victor Omollo; Felix Mogaka; Josephine Odoyo; Elizabeth A Bukusi; Jennifer F Morton; Rachel Johnson; Connie Celum; Jared M Baeten; Gabrielle O'Malley
Journal:  BMC Health Serv Res       Date:  2022-03-30       Impact factor: 2.655

8.  Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: A mixed-methods study.

Authors:  Lauren M Hill; Carol E Golin; Friday Saidi; Twambilile Phanga; Jennifer Tseka; Alinda Young; Lisa D Pearce; Suzanne Maman; Benjamin H Chi; Wilbroad Mutale
Journal:  J Int AIDS Soc       Date:  2022-09       Impact factor: 6.707

9.  Adaptation and psychometric evaluation of a scale to measure oral pre-exposure prophylaxis-related stigma among key and vulnerable populations in Kenya.

Authors:  Kaitlyn Atkins; Lena Kan; Abednego Musau; Jason Reed; Daniel Were; Diwakar Mohan
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

10.  The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub-Saharan Africa: state of the science and research priorities.

Authors:  Amelia M Stanton; Conall O'Cleirigh; Lucia Knight; Dvora L Joseph Davey; Landon Myer; John A Joska; Kenneth H Mayer; Linda-Gail Bekker; Christina Psaros
Journal:  J Int AIDS Soc       Date:  2022-10       Impact factor: 6.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.